Oncolytics Biotech Inc. (ONCY)
undefined
undefined%
At close: undefined
0.82
0.79%
After-hours Dec 13, 2024, 06:31 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Net Income -27.75M -24.84M -26.30M -22.51M -33.12M -17.04M -15.62M -15.14M -13.72M -18.62M -23.53M -36.37M -29.04M -19.97M -17.00M -17.55M -15.64M -14.30M -12.78M -12.96M -8.54M -6.09M -6.17M -3.61M -574.46K
Depreciation & Amortization 403.00K 392.00K 452.06K 446.19K 485.57K 95.38K 90.77K 162.23K 180.41K 163.50K 131.62K 109.28K 92.59K 63.16K 257.25K 410.25K 1.00M 926.68K 855.99K 751.75K 663.52K 574.24K 465.45K 205.20K 1.68K
Stock-Based Compensation 2.07M 2.38M 3.83M 2.56M 1.47M 1.42M 578.70K 406.08K 429.54K 980.33K 424.38K 730.75K 1.81M 3.25M 444.26K 64.04K - - - - - - - - -
Other Working Capital 1.26M 46.00K -131.59K -1.77M 221.34K -862.76K 4.95M 1.95M -957.16K -2.36M -1.31M 1.18M 3.56M -1.50M -663.81K 1.79M 530.30K 789.15K 584.76K -69.06K -486.17K -1.12M 1.77M 376.77K 38.43K
Other Non-Cash Items -4.93M -1.68M 91.73K 68.53K 94.82K 75.78K -124.79K 406.08K 429.54K 980.33K 424.38K 730.75K 814.91K -19.63M 116.02K 64.04K 539.16K 426.32K 288.61K 3.05M 2.89M -1 - - -
Deferred Income Tax - - 408.56K -2.85M 12.96M -374.34K - -545.89K -1.25M -737.78K -514.11K -640.86K - 19.97M - -64.04K - - - - - -647.62K -340.57K -126.81K -
Change in Working Capital 1.76M 391.00K -907.99K 209.78K -1.80M 3.90M 180.85K 2.23M -1.11M -2.44M -1.37M 1.19M 3.79M -1.72M -642.27K 1.79M 530.30K 789.15K 584.76K -69.06K -486.17K -1.12M 1.77M 376.77K 38.43K
Operating Cash Flow -28.45M -23.36M -22.43M -22.07M -19.91M -11.92M -14.89M -12.48M -15.03M -19.68M -24.44M -34.26M -22.54M -18.03M -16.82M -15.29M -13.57M -12.16M -11.05M -9.22M -5.48M -7.26M -4.27M -3.16M -534.35K
Capital Expenditures -8.00K -55.00K -285.95K -29.30K -10.90K -107.47K -105.77K -23.53K -108.27K -152.75K -254.83K -126.41K -257.79K -133.53K -9.76K -111.58K -944.72K -35.84K -61.31K -974.04K -1.10M -1.05M -585.51K -48.56K -19.97K
Acquisitions - - - - - - - - - - - - - - - -4.68B - - - - - - - - -
Purchase of Investments - -20.35M - - - - - -27.82K -29.29K - - -32.44K - -1.93M -1.76M -347.90K -949.50K -1.04M -22.20M -6.78M -18.11M - - - -
Sales Maturities Of Investments 20.23M - - - - - 2.09M - - - - - 1.67M - 6.12M 13.00M 6.57M 13.81M 6.66M 3.11M - - - - -
Other Investing Acitivies - -20.35K - - - - 2.09M -27.82 -29.29 -30.04K -32.42K -32.44 - - -0.00 4.68B - -842.61K -1.03M 133.61K 3.00M -147.47K - -324.26K -50.29K
Investing Cash Flow 20.22M -20.40M -285.95K -29.30K -10.90K -107.47K 1.98M -51.35K -137.56K -182.79K -287.25K -158.85K 1.41M -2.06M 4.35M 12.54M 4.68M 11.89M -16.62M -4.50M -16.21M -1.20M -585.51K -372.82K -70.26K
Debt Repayment -407.00K -381.00K -366.00K -461.00K -447.50K - - - 19.36M 1.21M - - - - - - - - - - - - - - 150.00K
Common Stock Repurchased - - - - - - - - - - - - - - - - - - - - - - - - -
Dividend Paid - - - - - - - - - - - - - - - - - - - - - - - - -
Other Financial Acitivies 781.00K 12.00K 469.68K 1.94M 3.47M 124.95K 343.44K - -19.36M -1.21M 179.24K 1.08M 14.82M 528.21K 17.01M 41.60K - - 15.40M 6.22M 15.30M 1.77M - 3.00M 1.90M
Financial Cash Flow 31.99M 12.21M 33.02M 39.77M 21.02M 13.30M 12.81M 956.13K 23.67M 9.04M 30.40M 20.85M 14.82M 27.29M 38.80M 3.46M 12.11M 241.40K 18.78M 23.50M 16.00M 1.80M 2.21M 16.60M 5.15M
Net Cash Flow 23.25M -29.60M 10.04M 17.07M 448.14K 1.86M -198.16K -11.98M 9.86M -11.07M 5.90M -13.60M -6.38M 6.85M 26.20M 714.80K 3.22M -19.85K -8.90M 9.77M -5.68M -6.65M -2.65M 13.07M 4.55M
Free Cash Flow -28.46M -23.41M -22.72M -22.10M -19.92M -12.03M -15.00M -12.50M -15.14M -19.83M -24.70M -34.38M -22.80M -18.17M -16.83M -15.40M -14.51M -12.19M -11.11M -10.20M -6.57M -8.31M -4.86M -3.21M -554.32K